ChemiCare
Novara · Founded 2016
About ChemiCare
A Start Up founded in December 2016 and committed to the discovery and development of orphan drugs for patients affected by calcium-related genetic diseases. ChemICare’s mission is the improvement of the quality of life of patients affected by Tubular Aggregate Myopathy, York Platelet Syndrome and Stormorken Syndrome by the development of a therapy that restores the abnormal intracellular calcium level, a common feature of these three rare diseases.
Company Facts
- Founded: 2016
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.3M
- Funding stage: Seed
- Last round: Seed (Dec 2025)
- Website: http://www.chemicare.it/
- Phone: [email protected]
Industries & Categories
Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/chemicare-3974 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.